Src tyrosine kinase is a novel direct effector of G pro... [Cell. 2000] - PubMed

Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases. [J Biol Chem. 2002]
Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases.
Poghosyan Z, Robbins SM, Houslay MD, Webster A, Murphy G, Edwards DR. J Biol Chem. 2002 Feb 15; 277(7):4999-5007. Epub 2001 Dec 10.
Constitutively active Galpha16 stimulates STAT3 via a c-Src/JAK- and ERK-dependent mechanism. [J Biol Chem. 2003]
Constitutively active Galpha16 stimulates STAT3 via a c-Src/JAK- and ERK-dependent mechanism.
Lo RK, Cheung H, Wong YH. J Biol Chem. 2003 Dec 26; 278(52):52154-65. Epub 2003 Oct 9.
Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. [Nature. 1997]
Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
Moarefi I, LaFevre-Bernt M, Sicheri F, Huse M, Lee CH, Kuriyan J, Miller WT. Nature. 1997 Feb 13; 385(6617):650-3.
Review Novel regulation and function of Src tyrosine kinase. [Cell Mol Life Sci. 2002]
Review Novel regulation and function of Src tyrosine kinase.
Ma YC, Huang XY. Cell Mol Life Sci. 2002 Mar; 59(3):456-62.
Review Multiple pathways of ERK activation by G protein-coupled receptors. [Novartis Found Symp. 2001]
Review Multiple pathways of ERK activation by G protein-coupled receptors.
Gudermann T. Novartis Found Symp. 2001; 239:68-79; discussion 80-4, 150-9.

P2Y receptors as regulators of lung endothelial barrier integrity. [J Cardiovasc Dis Res. 2011]
P2Y receptors as regulators of lung endothelial barrier integrity.
Zemskov E, Lucas R, Verin AD, Umapathy NS. J Cardiovasc Dis Res. 2011 Jan; 2(1):14-22.
Arrestin-2 differentially regulates PAR4 and ADP receptor signaling in platelets. [J Biol Chem. 2011]
Arrestin-2 differentially regulates PAR4 and ADP receptor signaling in platelets.
Li D, D'Angelo L, Chavez M, Woulfe DS. J Biol Chem. 2011 Feb 4; 286(5):3805-14. Epub 2010 Nov 24.
Promoter polymorphisms in the β-2 adrenergic receptor are associated with drug-induced gene expression changes and response in acute lymphoblastic leukemia. [Clin Pharmacol Ther. 2010]
Promoter polymorphisms in the β-2 adrenergic receptor are associated with drug-induced gene expression changes and response in acute lymphoblastic leukemia.
Pottier N, Paugh SW, Ding C, Pei D, Yang W, Das S, Cook EH, Pui CH, Relling MV, Cheok MH, et al. Clin Pharmacol Ther. 2010 Dec; 88(6):854-61. Epub 2010 Oct 27.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Src tyrosine kinase is a novel direct effector of G proteins.
Src tyrosine kinase is a novel direct effector of G proteins.
Cell. 2000 Sep 1 ;102(5):635-46.

PubMed
Methodological considerations in a community-based longitudinal study.
Methodological considerations in a community-based longitudinal study.
Am J Health Behav. 2009 Jan-Feb ;33(1):58-68.

PubMed
Human papillomavirus 16 E7 oncoprotein attenuates DNA damage checkpoint control ...
Human papillomavirus 16 E7 oncoprotein attenuates DNA damage checkpoint control by increasing the proteolytic turnover of claspin.
Cancer Res. 2009 Sep 1 ;69(17):7022-9. Epub 2009 Aug 25 .

PubMed
A 48-week, randomized, open-label comparison of three abacavir-based substitutio...
A 48-week, randomized, open-label comparison of three abacavir-based substitution approaches in the management of dyslipidemia and peripheral lipoatrophy.
J Acquir Immune Defic Syndr. 2003 May 1 ;33(1):22-8.

PubMed
The pathophysiology and treatment of sepsis.
The pathophysiology and treatment of sepsis.
N Engl J Med. 2003 Jan 9 ;348(2):138-50.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed